Latigo Biotherapeutics Inc

Latigo Biotherapeutics Inc. is a privately held company located in Thousand Oaks, California. As a clinical-stage biotechnology company, Latigo Biotherapeutics employs 38 people. Latigo Biotherapeutics develops non-opioid pain medications focused on the core mechanisms of pain transmission. Their technology leverages artificial intelligence, machine learning, structure-based, and knowledge-based design techniques to create novel drugs targeting pain receptors validated by human genetics. The company's proprietary technology aims to generate drugs with optimized potency and selectivity. Latigo Biotherapeutics is supported by a strong investor base, including prominent firms such as Westlake Village BioPartners, 5AM Ventures, Foresite Capital, and Corner Ventures. For more information about Latigo Biotherapeutics Inc., visit their website at latigobio.com.